tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emmanuel Papadakis, 33 are a SELL (20.89%), 74 are a HOLD (46.84%), 51 are a BUY (32.28%).
Analyst Emmanuel Papadakis, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 61.67% that have a potential upside of 30.94% achieved within 252 days. Previously, Emmanuel Papadakis worked at UBS, BARCLAYS, LEERINK.
Emmanuel Papadakis’s has documented 246 price targets and ratings displayed on 20 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive, Consumer Cyclical sectors.
Most recent stock forecast was given on NVS, Novartis AG ADR at 30-Oct-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 3/7/2022. The price target of $155 was fulfilled within 9 days with a profit of $28.54 (22.57%) receiving and performance score of 25.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$240
$53.57 (28.73%)
$105
7 months 14 days ago
(30-Mar-2026)
12/15 (80%)
$47.4 (24.61%)
572
Buy Since 27-Jan-2020
$220
$33.57 (18.01%)
$174
7 months 17 days ago
(27-Mar-2026)
5/16 (31.25%)
$32.82 (17.53%)
570
Buy Since 11-Apr-2023
$109
$-77.43 (-41.53%)
$168
8 months 11 days ago
(02-Mar-2026)
1/3 (33.33%)
$-93.39 (-46.14%)
128
Buy Since 26-Jan-2018
$108.5
$-77.93 (-41.80%)
11 months 19 days ago
(25-Nov-2025)
6/7 (85.71%)
$-74.82 (-40.81%)
856
Hold Since 27-Oct-2025
1 years 17 days ago
(27-Oct-2025)
2/3 (66.67%)
$-6.12 (-4.81%)
958
Which stock is Emmanuel Papadakis most bullish on?
What Year was the first public recommendation made by Emmanuel Papadakis?
